Stifel Financial Corp Trims Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Stifel Financial Corp cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 0.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 79,857 shares of the medical instruments supplier’s stock after selling 60 shares during the period. Stifel Financial Corp owned approximately 0.11% of West Pharmaceutical Services worth $28,680,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Eudaimonia Partners LLC raised its stake in shares of West Pharmaceutical Services by 1,396.4% during the 2nd quarter. Eudaimonia Partners LLC now owns 1,646 shares of the medical instruments supplier’s stock worth $591,000 after buying an additional 1,536 shares in the last quarter. Bridgewater Associates LP raised its stake in shares of West Pharmaceutical Services by 80.6% during the 2nd quarter. Bridgewater Associates LP now owns 87,568 shares of the medical instruments supplier’s stock worth $31,446,000 after buying an additional 39,073 shares in the last quarter. Blueshift Asset Management LLC purchased a new position in shares of West Pharmaceutical Services during the 2nd quarter worth approximately $2,838,000. Azimuth Capital Management LLC raised its stake in shares of West Pharmaceutical Services by 2.0% during the 2nd quarter. Azimuth Capital Management LLC now owns 48,923 shares of the medical instruments supplier’s stock worth $17,568,000 after buying an additional 972 shares in the last quarter. Finally, Qube Research & Technologies Ltd raised its stake in shares of West Pharmaceutical Services by 40.9% during the 2nd quarter. Qube Research & Technologies Ltd now owns 14,594 shares of the medical instruments supplier’s stock worth $5,241,000 after buying an additional 4,234 shares in the last quarter. 92.74% of the stock is owned by hedge funds and other institutional investors.

In other West Pharmaceutical Services news, VP Quintin J. Lai sold 9,672 shares of the stock in a transaction on Friday, September 10th. The stock was sold at an average price of $460.76, for a total transaction of $4,456,470.72. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.66% of the company’s stock.

NYSE WST opened at $402.25 on Thursday. West Pharmaceutical Services, Inc. has a 1-year low of $253.85 and a 1-year high of $475.35. The company has a market capitalization of $29.76 billion, a P/E ratio of 58.81, a PEG ratio of 1.96 and a beta of 1.00. The business has a 50 day moving average price of $439.24 and a 200 day moving average price of $376.19. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.13 and a quick ratio of 2.39.

West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings data on Thursday, July 29th. The medical instruments supplier reported $2.46 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.72. West Pharmaceutical Services had a return on equity of 28.58% and a net margin of 20.58%. The firm had revenue of $723.60 million during the quarter, compared to the consensus estimate of $665.55 million. On average, research analysts expect that West Pharmaceutical Services, Inc. will post 8.22 earnings per share for the current fiscal year.

Separately, KeyCorp increased their target price on West Pharmaceutical Services from $350.00 to $475.00 and gave the stock an “overweight” rating in a research note on Friday, July 30th.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers.

Further Reading: Fibonacci Channel

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.